
Key points:
- Temsirolimus gives a new way of treating malignant pleural mesothelioma
- Temsirolimus is a kinase inhibitor used to treat advanced renal cell carcinoma (RCC)
- The conclusion was published in the Journal of Oncology Reports
- Temsirolimus works against mesothelioma cells by blocking the action of a gene pathway called mammalian target of rapamycin (mTOR)
- Temsirolimus can also be used to prevent the formation of blood vessels that...